Results

Total Results: 979 records

Showing results for "medication".
Users also searched for: medication reconciliation

1. Clinical Summary: Medication Use to Reduce Risk of Breast Cancer (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z3BVaJRtyu8drWSHWYT_Yf
   Clinical Summary: Medication Use to Reduce Risk of Breast Cancer Clinical Summary: Medication Use … benefit of risk reduction of breast cancer must be balanced against the potential harms of adverse medication

2. Recommendation: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/breast-cancer-medication-use-reduce-risk
   March 14, 2024 - Share to WhatsApp Share to Email Print Breast Cancer: Medication … See Current Final Recommendation Statement for Breast Cancer: Medication Use to Reduce Risk(2019)

3. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
   April 26, 2022 - Final Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Persons who place a higher value on the potential harms or the burden of taking a daily preventive medication … benefits expressed as quality-adjusted life-years and life-years. 26 , 27 Benefits of Preventive Medication … some cases, CRC outcomes data were collected by outside investigators. 14 , 25 Harms of Preventive Medication … bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication

4. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
   September 03, 2019 - to Email Print Final Recommendation Statement Breast Cancer: Medication … Update in Progress for Breast Cancer: Medication to Reduce Risk … aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the … Medication use for the risk reduction of primary breast cancer in women: updated evidence report and

5. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
   August 23, 2022 - Recommendation Statement Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … preference for a potential small benefit relative to the potential harms and inconvenience of taking a daily medication … higher value on the potential benefits than on the potential harms and inconvenience of taking a daily medication … Benefits of Preventive Medication The USPSTF reviewed 22 trials that reported on the benefits of statin … As noted, most trials used a moderate-intensity statin. 13 , 31 Harms of Preventive Medication The

6. Archived: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
   July 15, 2011 - Final Recommendation Statement Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … Recommendation Grade All Newborns The USPSTF recommends prophylactic ocular topical medication … Benefits of Risk Assessment and Preventive Medication There is convincing evidence that blindness due … Preventive Medication Prophylactic regimens using 1.0% tetracycline or 0.5% erythromycin ophthalmic … Gonococcal Infection in Neonates, Ocular Topical Medication.

7. Search Results | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/topic_search_results?topic_status=P
   January 01, 2025 - Male Pregnant Type of Preventive Service Counseling Preventive medication … Adult, Senior B, I Musculoskeletal Disorders Published Preventive medication … Pediatric I Development and Behavior Published Counseling, Preventive medication … Adult B Obstetric and Gynecologic Conditions Published Preventive medication … 2023 Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication

8. Search Results | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/topic_search_results
   January 01, 2025 - Male Pregnant Type of Preventive Service Counseling Preventive medication … Adult, Senior B, I Musculoskeletal Disorders Published Preventive medication … Pediatric I Development and Behavior Published Counseling, Preventive medication … Adult B Obstetric and Gynecologic Conditions Published Preventive medication … 2023 Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication

9. Final Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
   March 21, 2024 - to Email Print in progress Final Research Plan Breast Cancer: Medication … or unavailable in the United States Comparisons Placebo, no treatment, or active comparator medication

10. Draft Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
    December 28, 2023 - to Email Print in progress Draft Research Plan Breast Cancer: Medication … or unavailable in the United States Comparisons Placebo, no treatment, or active comparator medication

11. Recommendation: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
    December 17, 2024 - Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication … Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication

12. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

13. Recommendation: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
    January 29, 2019 - Final Recommendation Statement Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … All Population Newborns Recommendation Provide prophylactic ocular topical medication … Grade: A Preventive Medication Erythromycin ophthalmic ointment is the only drug approved by … Potential Harms of Preventive Medication The USPSTF found no new data that would change its previous … Possible harms include the potential for antimicrobial resistance to treatment medication.

14. Update Existing Topic | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominating-recommendation-statement-topics/update-an-existing-prevention-recommendation
    June 22, 2025 - Anxiety in Children and Adolescents: Screening Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication Asymptomatic … Community-Dwelling Older Adults: Interventions Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication … Children: Screening Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

15. Archived: Aspirin Prophylaxis in Pregnancy: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-pregnancy-1996
    January 01, 1996 - archived Final Recommendation Statement Aspirin Prophylaxis in Pregnancy: Preventive Medication … Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … trial, 315 of 919 women failed a 2-week run-in period due to poor compliance with either visits or medication

16. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - Evidence Summary Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … recommendation statement: statin use for the primary prevention of cardiovascular disease in adults: preventive medication … https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication … BMI <35 a HbA 1c <12% SBP <200 mm Hg DBP <110 mm Hg Not receiving any other lipid-lowering medication … early-morning spot sample and 15 to 300 mg in two 24-hour samples) BP <160/100 mm Hg and no antihypertensive medication

17. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement … Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement … Clinical Review & Education US Preventive Services Task Force USPSTF Recommendation: Medication Use to … Clinical Summary: Medication Use to Reduce Risk of Breast Cancer Population Recommendation Women … Based on limited survey data, 10% to 30% (depending on medication type) of pri- mary care clinicians

18. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Print Evidence Summary Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … often have higher bleeding risk either due to risk factors (smoking, uncontrolled hypertension) or co-medication … bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication

19. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Print Modeling Study Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

20. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Share to Email Print Final Recommendation Statement Breast Cancer: Medication … Duration of Medication Use and Persistence of Effects In trials, participants typically used risk-reducing … Based on limited survey data, 10% to 30% (depending on medication type) of primary care clinicians report … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the … Medication use for the risk reduction of primary breast cancer in women: updated evidence report and